Liver cell cytoplasmic inclusions in experimental porphyrias: Their demonstration with the ferric ferricyanide reduction reaction

Experimental and Toxicologic Pathology

Volumn 49, Issue 3-4, 1997, Pages 289-293

  Fakan, František ^a   Chlumská, Alena ^a   Krijt, Jan ^a   Šafanda, Jiři ^a   Michal, Michal ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cytoplasmic inclusions; Ferric ferricyanide reduction reaction; Hepatic cell; Inclusions; Liver cell; Porphyria

Indexed keywords

FERRICYANIDE; FOMESAFEN; HEXACHLOROBENZENE; POLYCHLORINATED BIPHENYL;

ANIMAL CELL; ARTICLE; CELL INCLUSION; FEMALE; HISTOLOGY; LIVER CELL; MOUSE; NONHUMAN; PORPHYRIA; RAT; REDUCTION;

ANIMALIA;

EID: 0030794915     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(97)80038-3     Document Type: Article

References (18)

1. CORTÉZ JM, OLIVA H, PARADINAS FJ, et al.: The pathology of the liver in porphyria cutanea tarda. Histopathology 1980; 4: 471-485.
2. DE MATTEIS, PRIOR BE, RIMINGTON C: Nervous and biochemical disturbances following hexachlorbenzene intoxication. Nature 1961; 191: 363-366.
3. DE MATTEIS F: Drug-induced abnormalities of liver heme biosynthesis. In: MEEKS RG, HARRISON SD, BULL RJ (eds): Hepatotoxicology. Boca Raton FL, CRC Press 1991; 437-478.
4. FAKAN F, CHLUMSKÁ A: Demonstration of needle-shaped hepatic inclusions in porphyria cutanea tarda using the ferric ferricyanide reduction test. Virchows Arch A 1987; 411: 365-368.
5. KEMMER CH, RIEDEL H, KOSTLER E, et al.: Zur Bedeutung parakristalliner Nadelstrukturen für die Diagnose der chronischen hepatischen Porphyrie - licht- und elektronenmikroskopische Untersuchungen an Biopsienmaterial. Zbl allg Pathol, pathol Anat 1983; 127: 253-264.
6. KRIJT J, SANITRÁK J, VOKURKA M, et al.: Liver high performance liquid chromatographic porphyrin profiles in experimental porphyria induced by peroxidizing herbicides. Biomed Chromatogr 1991; 5: 229-230.
7. KRIJT J, VAN HOLSTEIJN I, HASSING I, et al.: Effect of diphenyl ether herbicides and oxadiazon on porphyrin biosynthesis in mouse liver, rat primary hepatocyte culture and HepG2 cells. Arch Toxicol 1993; 67: 255-261.
8. KRIJT J, VOKURKA M, SANITRAK J, et al.: Effect of the protoporphyrinogen oxidase-inhibiting herbicide fomesafen on liver uroporphyrin and heptacarboxylic porphyrin in two mouse strains. Fd Chem Toxicol 1994; 32: 641-649.
9. KRISHAN K, BRODEUR J, CHARBONNEAU M: Development of an experimental model for the study of hexachlorbenzene-induced hepatic porphyria in the rat. Fd Appl Toxicol 1991; 17: 433-441.
10. LILLIE RD: Histopathologie technic and practical histochemistry. 3rd ed. New York, Mc Graw-Hill, 1965.
11. LILLIE RD, DONALDSON PT: The mechanism of the ferric ferricyanide reduction reaction. Histochem J 1974; 6: 679-684.
12. OCKNER RK, SCHMID R: Acquired porphyria in man and rat due to hexachlorbenzene intoxication. Nature 1961; 189: 499.
13. SIERSEMA PD, VAN HELVOIRT RP, KETELAARS AM, et al.: Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: a biochemical and morphological study. Hepatology 1991; 14: 1179-1188.
14. SIERSEMA PD, CLETON-SOETEMAN MI, DE BRUJN WC, et al.: Ferritin accumulation and uroporphyrin crystal formation in hepatocytes of C57BL/10 mice: a time-course study. Cell Tissue Res 1993; 274; 405-412.
15. STRIK JJTWA, DEBETS FMH, KOSS G: Chemical porphyria. In: KIMBROUGH RD (ed): Halogenated biphenyls, terphenyls, naphthalens, dibenzodioxins and related products. Amsterdam Elsevier/North Holland 1980; pp. 191-239.
16. TIMME AH, DOWDLE EB, EALES L: Symptomatic porphyria. Part I. The pathology of the liver in human symptomatic porphyria. South Afr Med J 1974a; 48: 1803-1807.
17. TIMME AH, TALJAARD JJF, SHANLEY BC, et al.: Symptomatic porphyria. Part II. Hepatic changes with hexachlorbenzene. South Afr Med J 1974b; 48: 1833-1836.
18. WALDO ED, TOBIAS H: Needle-like cytoplasmic inclusions in the liver in porphyria cutanea tarda. Arch Pathol 1973; 96: 368-371.